Pharmaceutical Granulation Equipment Market Report: Trends, Forecast and Competitive Analysis to 2031

Pharmaceutical Granulation Equipment Market Trends and Forecast

The future of the global pharmaceutical granulation equipment market looks promising with opportunities in the pharmaceutical manufacturing companies and contract manufacturing markets. The global pharmaceutical granulation equipment market is expected to grow with a CAGR of 5.6% from 2025 to 2031. The major drivers for this market are the increasing demand for high-quality pharmaceutical products, the rising adoption of advanced granulation technologies, and the growing need for efficient manufacturing processes.

• Lucintel forecasts that, within the type category, high sheer granulator is expected to witness the highest growth over the forecast period.

• Within the end use category, contract manufacturing is expected to witness higher growth.

• In terms of region, APAC is expected to witness the highest growth over the forecast period. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Pharmaceutical Granulation Equipment Market

Emerging trends are reshaping the pharmaceutical granulation equipment market by focusing on enhanced efficiency, quality, and flexibility. These trends are a direct response to the industry's need for more streamlined production processes, stringent quality control, and the ability to adapt to a wider range of drug formulations. The goal is to make granulation a more predictable and cost-effective process.

• Continuous Manufacturing Adoption: A significant trend is the shift from traditional batch processing to continuous granulation. The impact is enhanced efficiency, consistent product quality, and reduced production times. This approach minimizes human intervention, lowers the risk of batch-to-batch variability, and allows for real-time monitoring, which is crucial for meeting stringent regulatory standards and optimizing production costs.

• Integration of Industry 4.0 Technologies: The market is seeing a trend toward integrating technologies like IoT, AI, and real-time data analytics. The impact is greater process control and predictive maintenance. These smart systems enable manufacturers to monitor granulation parameters with greater precision, predict equipment failures, and optimize production processes, thereby reducing downtime and ensuring product consistency.

• Modular and Flexible Equipment: There is a trend towards the development of modular and skid-mounted granulation units. The impact is increased flexibility and faster scalability for manufacturers. These "plug-and-play" systems allow companies, particularly contract manufacturing organizations (CMOs) and generics producers, to quickly reconfigure their production lines to accommodate different products and scales, which is highly advantageous in a competitive market.

• Focus on Dry Granulation Techniques: The market is seeing a growing trend toward dry granulation methods, such as roller compactors. The impact is a more efficient and solvent-free process. Dry granulation is ideal for moisture-sensitive and heat-sensitive APIs, as it eliminates the need for liquid binders and drying, reducing production time and energy costs, and is increasingly seen as a more sustainable alternative.

• Advanced Process Analytical Technology: A key trend is the wider adoption of Process Analytical Technology (PAT) tools in granulation. The impact is real-time quality control and improved compliance. By using tools like NIR and Raman spectroscopy, manufacturers can monitor critical process parameters, such as moisture and blend uniformity, in real time, which ensures product quality and enables real-time release testing. These emerging trends are fundamentally reshaping the pharmaceutical granulation equipment market by transforming it into a more efficient, data-driven, and adaptable industry. The focus has shifted to automation, real-time quality control, and flexibility, which is not only driving market growth but also enabling manufacturers to produce a wider range of high-quality, safe, and effective solid dosage forms.

Recent Development in the Pharmaceutical Granulation Equipment Market

Recent developments in the pharmaceutical granulation equipment market are focused on improving process efficiency, ensuring product quality, and enhancing regulatory compliance. These developments are a direct response to the industry's need for more sophisticated and reliable equipment to produce complex solid dosage forms. The goal is to provide manufacturers with a comprehensive range of solutions that can meet modern production challenges.

• Development of Single-Pot Granulators: A significant development is the introduction of single-pot granulators that combine multiple processes, such as mixing, granulation, and drying, into a single unit. The impact is a streamlined workflow and a reduced risk of contamination. These all-in-one systems reduce handling and transfer steps, which increases efficiency and is crucial for maintaining a clean and sterile environment.

• Advancements in High-Shear Granulators: A key development is the continuous advancement in high-shear granulators with improved impeller designs and control systems. The impact is a more precise control over granule size and density. These new designs enhance the mixing and densification process, ensuring that the granules have the desired properties for subsequent compression into tablets or filling into capsules.

• Strategic Partnerships & Acquisitions: The market has seen a development in strategic partnerships and acquisitions among equipment manufacturers. The impact is an acceleration of innovation and market consolidation. These collaborations allow companies to pool resources for R&D, expand their product portfolios, and increase their global market reach, creating a more competitive and dynamic industry.

• Launch of Advanced Roller Compactors: Recent developments include the launch of new, advanced roller compactors with improved gap control and higher-pressure capabilities. The impact is a more consistent and efficient dry granulation process. These machines are a vital development for manufacturers working with moisture-sensitive APIs, offering a reliable alternative to traditional wet granulation methods.

• Focus on Contained Granulation Systems: The market is seeing a development in the launch of contained granulation systems for handling highly potent or hazardous APIs. The impact is enhanced operator safety and environmental protection. These systems are designed to prevent the escape of dust and other hazardous materials, which is crucial for protecting workers and ensuring compliance with occupational health and safety regulations. These developments are having a profound impact on the pharmaceutical granulation equipment market by accelerating the transition to a more modern and integrated manufacturing model. The focus on new technologies, automation, and a holistic approach to process efficiency is not only driving market growth but also enabling manufacturers to produce safer and more effective drugs.

Strategic Growth Opportunities in the Pharmaceutical Granulation Equipment Market

Strategic growth opportunities in the pharmaceutical granulation equipment market are concentrated on key applications and technologies that address the evolving needs of the industry. These opportunities are driven by the rising demand for solid dosage forms, the push for more efficient manufacturing processes, and the need for equipment that can handle a wider range of drug formulations. The focus is on leveraging innovation to capture new market segments.

• High-Potency Active Pharmaceutical Ingredients: The growing use of highly potent APIs in drug formulations is a major growth opportunity. The impact is an increased demand for contained granulation systems that ensure operator safety and prevent cross-contamination. This niche market requires specialized equipment that can handle hazardous materials, creating a lucrative segment for manufacturers.

• Continuous Manufacturing for Generics: A key strategic opportunity is in providing continuous granulation systems for generic drug manufacturers. The impact is a reduction in production costs and a faster time to market. As generics companies face intense price competition, continuous manufacturing offers a way to improve efficiency, reduce waste, and meet the high-volume demand for common medications.

• R&D and Pilot-Scale Applications: There is a growth opportunity in developing compact, versatile granulation equipment for R&D and pilot-scale applications. The impact is an acceleration of new drug development. These smaller-scale machines allow for the quick testing and optimization of new formulations without the need for large-scale production equipment, which is crucial for pharmaceutical innovation.

• Biologics and Biopharmaceuticals: The increasing use of biologics and biopharmaceuticals, which are often sensitive to heat and moisture, presents a strategic opportunity for dry granulation equipment. The impact is a safer and more effective manufacturing process for these complex drugs. Dry granulation can preserve the integrity of these delicate molecules, offering a valuable alternative to traditional wet granulation methods.

• Contract Manufacturing Organizations: The rising trend of pharmaceutical companies outsourcing their manufacturing to CMOs is a significant growth opportunity. The impact is a high demand for flexible and multi-purpose granulation equipment. CMOs need versatile systems that can quickly switch between different products and processes, making them a key customer segment for equipment manufacturers. These strategic growth opportunities are reshaping the pharmaceutical granulation equipment market by diversifying its applications and integrating it into a broader manufacturing and R&D landscape. The focus on new technologies, specialized applications, and a flexible approach is driving market innovation and positioning granulation equipment as a central tool for modern pharmaceutical production.

Pharmaceutical Granulation Equipment Market Driver and Challenges

Major drivers and challenges impacting the pharmaceutical granulation equipment market are a complex interplay of technological, economic, and regulatory factors. These forces are influencing market growth and shaping the competitive landscape. While the increasing demand for solid dosage forms and a growing focus on continuous manufacturing are propelling the market forward, issues related to high costs, regulatory complexities, and technical challenges pose significant hurdles. The factors responsible for driving the pharmaceutical granulation equipment market include: 1. Rising Demand for Solid Dosage Forms: The increasing global demand for solid dosage forms, such as tablets and capsules, is a primary market driver. This widespread use of solid drugs, particularly in generic and over-the-counter medications, creates a sustained need for efficient and high-quality granulation equipment for their production. 2. Technological Advancements in Automation: Significant technological advancements in automation and control systems are a major driver. These innovations enhance process efficiency, reduce human error, and enable real-time monitoring, which is crucial for meeting stringent quality standards and optimizing production in a highly competitive industry. 3. Focus on Continuous Manufacturing: The growing shift from traditional batch processing to continuous manufacturing is a key driver. This modern approach offers advantages in terms of reduced production time, lower operational costs, and consistent product quality, which is making it a preferred choice for many pharmaceutical manufacturers. 4. Stringent Regulatory Requirements: Increasingly stringent regulatory requirements from bodies like the FDA and EMA are a major driver. These regulations, particularly the emphasis on Quality by Design (QbD) and process validation, are pushing manufacturers to invest in advanced granulation equipment that can provide real-time data and ensure consistent product quality. 5. Growth of the Generics Market: The rapid growth of the global generics market is a significant driver. Generic drug manufacturers require high-volume, cost-effective production methods, and modern granulation equipment, especially continuous systems, offers the efficiency and scalability needed to meet this demand and maintain competitiveness. Challenges in the pharmaceutical granulation equipment market are: 1. High Initial Investment Cost: The significant initial capital investment required for advanced granulation equipment, particularly continuous and automated systems, is a major challenge. This high cost can be a barrier for small and mid-sized pharmaceutical companies, limiting their ability to upgrade their facilities and adopt new technologies. 2. Complexities in Technology Transfer: A key challenge is the complexities involved in transferring and scaling up a granulation process from R&D to full-scale production. Differences in equipment, scale, and process parameters can lead to inconsistencies in the final product, which is a significant barrier to the adoption of new and innovative granulation techniques. 3. Regulatory and Validation Hurdles: Stringent regulatory requirements and the complexities of validating new equipment and processes pose a significant challenge. The time and cost associated with validating a new granulation system can be substantial, which can slow down the adoption of new technologies and delay time to market for new drugs. The overall impact of these drivers and challenges is a market that is expanding, but with significant constraints. While the demand for efficient production and a robust pipeline is creating a strong impetus for growth, issues of cost, technological complexity, and regulation are creating a competitive and sometimes restrictive environment. The market's future will depend on its ability to produce more affordable, user-friendly, and well-supported products to overcome these hurdles.

List of Pharmaceutical Granulation Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical granulation equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical granulation equipment companies profiled in this report include-

• Alexanderwerk

• Anchor Mark

• Fluid Air

• HOSOKAWA MICRON

• GEA Group

• M.A. INDUSTRIA MACCHINE AUTOMATICHE

• L.B. Bohle Maschinen und Verfahren

• LFA Machines Oxford

• PTK-GB Limited

• Romaco Group

Pharmaceutical Granulation Equipment Market by Segment

The study includes a forecast for the global pharmaceutical granulation equipment market by type, mechanism, end use, and region.

Pharmaceutical Granulation Equipment Market by Type [Value from 2019 to 2031]:

• Single Pot Granulators

• High Sheer Granulators

• Oscillating Granulators

• Others

Pharmaceutical Granulation Equipment Market by Mechanism [Value from 2019 to 2031]:

• Dry Granulators

• Wet Granulators

• Mixture Granulators

Pharmaceutical Granulation Equipment Market by End Use [Value from 2019 to 2031]:

• Pharmaceutical Manufacturing Companies

• Contract Manufacturing

• Others

Pharmaceutical Granulation Equipment Market by Region [Value from 2019 to 2031]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Pharmaceutical Granulation Equipment Market

The pharmaceutical granulation equipment market is a dynamic sector driven by the constant need for efficient and high-quality solid dosage form production. Recent developments are focused on addressing key industry challenges, such as process optimization, quality control, and regulatory compliance. The market is evolving with the integration of advanced technologies like automation and continuous manufacturing, moving away from traditional batch processes to enhance productivity and consistency.

• United States: The U.S. market is a leader in technological innovation and R&D investment. Recent developments include a significant shift towards continuous granulation processes, which improve efficiency and quality control. The market is also seeing increased investment in smart granulation equipment with integrated sensors and real-time monitoring to ensure compliance with stringent regulatory standards.

• China: China's market is experiencing rapid growth, driven by a burgeoning pharmaceutical industry and increased healthcare spending. Recent developments are centered on adopting more advanced granulation equipment, including both high-shear and fluid-bed granulators. The government's push for high-quality domestic drug manufacturing is fueling demand for modern equipment to meet international quality standards and regulatory requirements.

• Germany: In Germany, the market is defined by a strong emphasis on precision engineering and advanced technology. Developments are focused on creating highly automated and energy-efficient granulation systems that align with sustainability goals. The market is also seeing a growing integration of Industry 4.0 concepts, such as IoT and real-time data analytics, to optimize granulation parameters and ensure consistent product quality.

• India: The Indian market is growing steadily, propelled by a strong generic drug manufacturing base and a focus on cost-effective solutions. Recent developments include a growing number of domestic manufacturers offering a range of granulation equipment. The market is also seeing an increasing demand for both traditional batch and continuous granulation systems to meet the diverse needs of its expanding pharmaceutical industry.

• Japan: Japan's market is technologically sophisticated, with a strong focus on quality and innovation. Developments are concentrated on advanced granulation techniques to produce specialized drug formulations. The market is also seeing a growing demand for compact and modular granulation systems that are suitable for both R&D and small-scale production, reflecting the country's emphasis on new drug development.

Features of the Global Pharmaceutical Granulation Equipment Market

Market Size Estimates: Pharmaceutical granulation equipment market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions. Segmentation Analysis: Pharmaceutical granulation equipment market size by type, mechanism, end use, and region in terms of value ($B). Regional Analysis: Pharmaceutical granulation equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, mechanisms, end uses, and regions for the pharmaceutical granulation equipment market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pharmaceutical granulation equipment market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for pharmaceutical granulation equipment market? Answer: The global pharmaceutical granulation equipment market is expected to grow with a CAGR of 5.6% from 2025 to 2031. Q2. What are the major drivers influencing the growth of the pharmaceutical granulation equipment market? Answer: The major drivers for this market are the increasing demand for high-quality pharmaceutical products, the rising adoption of advanced granulation technologies, and the growing need for efficient manufacturing processes. Q3. What are the major segments for pharmaceutical granulation equipment market? Answer: The future of the pharmaceutical granulation equipment market looks promising with opportunities in the pharmaceutical manufacturing companies and contract manufacturing markets. Q4. Who are the key pharmaceutical granulation equipment market companies? Answer: Some of the key pharmaceutical granulation equipment companies are as follows:

• Alexanderwerk

• Anchor Mark

• Fluid Air

• HOSOKAWA MICRON

• GEA Group

• M.A. INDUSTRIA MACCHINE AUTOMATICHE

• L.B. Bohle Maschinen und Verfahren

• LFA Machines Oxford

• PTK-GB Limited

• Romaco Group Q5. Which pharmaceutical granulation equipment market segment will be the largest in future? Answer: Lucintel forecasts that, within the type category, high sheer granulator is expected to witness the highest growth over the forecast period. Q6. In pharmaceutical granulation equipment market, which region is expected to be the largest in next 5 years? Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.